Vuno
Helping doctors interpret patient data from imaging modalities including X-rays and CT scans to biosignal monitoring systems.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | KRW10.4b | Convertible |
| Total Funding | 000k | ||
| KRW | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 268 % | 60 % | 95 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (831 %) | (166 %) | (128 %) | (41 %) |
| Profit | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (870 %) | (189 %) | (118 %) | (50 %) |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 226 % | 59 % | 35 % | 20 % |
Source: Company filings or news article
Related Content
VUNO Inc. is a pioneering company in the field of medical artificial intelligence (AI), specializing in the development of AI-driven diagnostic and data analysis solutions for the healthcare industry. The company serves a diverse range of clients, including hospitals, clinics, and medical research institutions, by providing advanced tools that assist in the diagnosis and monitoring of diseases. VUNO operates in the global healthcare market, with a particular focus on imaging modalities such as X-rays and CT scans, as well as biosignal monitoring systems.
The business model of VUNO revolves around the creation and licensing of AI-based software solutions that quantify and analyze medical data. These solutions help healthcare providers make more accurate diagnoses and improve patient outcomes. VUNO generates revenue through the sale of software licenses, consulting services, and platform subscriptions. The company has achieved significant milestones, including obtaining CE marks for several of its medical AI solutions, which indicates compliance with European health, safety, and environmental protection standards.
VUNO's commitment to innovation is evident in its continuous development of new AI technologies and its expansion into international markets, such as Japan. By leveraging cutting-edge AI, VUNO aims to transform the way medical data is analyzed and utilized, ultimately contributing to better healthcare worldwide.
Keywords: AI, medical data analysis, diagnostic solutions, healthcare, imaging modalities, biosignal monitoring, software licensing, consulting services, CE mark, international expansion.
